Neurofilaments in blood: (Almost) facing clinical application

Michelle M. Mielke; Markus Otto

doi:10.1212/WNL.0000000000004675

Neurofilaments in blood: (Almost) facing clinical application

Health Sciences Research

Research output: Contribution to journal › Editorial › peer-review

Original language	English (US)
Pages (from-to)	2126-2127
Number of pages	2
Journal	Neurology
Volume	89
Issue number	21
DOIs	https://doi.org/10.1212/WNL.0000000000004675
State	Published - 2017

ASJC Scopus subject areas

Clinical Neurology

Access to Document

10.1212/WNL.0000000000004675

Cite this

@article{80a426246a6645aa8994d9294e3aa59a,

title = "Neurofilaments in blood: (Almost) facing clinical application",

author = "Mielke, {Michelle M.} and Markus Otto",

note = "Funding Information: Dr. Mielke served as a consultant to Eli Lilly and Lysosomal Therapeutics, Inc. She receives research support from the NIH (R01 AG49704, P50 AG44170, U01 AG06786, RF1 AG55151), Department of Defense (W81XWH-15-1), and unrestricted research grants from Biogen, Roche, and Lundbeck. Dr. Otto served as consultant for Biogen and Axon. He receives research funding from the European commission (Fairpark-II), German Federal Ministry of Education and Research (KNDD-FTLDc), JPND (Prefrontals), Thierry Latran foundation, Foundation of the state Baden- Wuerttemberg, Boehringer Ingelheim Ulm University BioCenter (BIU), and German Research Foundation (SFB 1279). Go to Neurology.org for full disclosures. Funding Information: Dr. Mielke served as a consultant to Eli Lilly and Lysosomal Therapeutics, Inc. She receives research support from the NIH (R01 AG49704, P50 AG44170, U01 AG06786, RF1 AG55151), Department of Defense (W81XWH-15-1), and unrestricted research grants from Biogen, Roche, and Lundbeck. Dr. Otto served as consultant for Biogen and Axon. He receives research funding from the European commission (Fairpark-II), German Federal Ministry of Education and Research (KNDD-FTLDc), JPND (Prefrontals), Thierry Latran foundation, Foundation of the state Baden-Wuerttemberg, Boehringer Ingelheim Ulm University BioCenter (BIU), and German Research Foundation (SFB 1279). Go to Neurology.org for full disclosures.",

year = "2017",

doi = "10.1212/WNL.0000000000004675",

language = "English (US)",

volume = "89",

pages = "2126--2127",

journal = "Neurology",

issn = "0028-3878",

publisher = "Lippincott Williams and Wilkins",

number = "21",

}

TY - JOUR

T1 - Neurofilaments in blood

T2 - (Almost) facing clinical application

AU - Mielke, Michelle M.

AU - Otto, Markus

N1 - Funding Information: Dr. Mielke served as a consultant to Eli Lilly and Lysosomal Therapeutics, Inc. She receives research support from the NIH (R01 AG49704, P50 AG44170, U01 AG06786, RF1 AG55151), Department of Defense (W81XWH-15-1), and unrestricted research grants from Biogen, Roche, and Lundbeck. Dr. Otto served as consultant for Biogen and Axon. He receives research funding from the European commission (Fairpark-II), German Federal Ministry of Education and Research (KNDD-FTLDc), JPND (Prefrontals), Thierry Latran foundation, Foundation of the state Baden- Wuerttemberg, Boehringer Ingelheim Ulm University BioCenter (BIU), and German Research Foundation (SFB 1279). Go to Neurology.org for full disclosures. Funding Information: Dr. Mielke served as a consultant to Eli Lilly and Lysosomal Therapeutics, Inc. She receives research support from the NIH (R01 AG49704, P50 AG44170, U01 AG06786, RF1 AG55151), Department of Defense (W81XWH-15-1), and unrestricted research grants from Biogen, Roche, and Lundbeck. Dr. Otto served as consultant for Biogen and Axon. He receives research funding from the European commission (Fairpark-II), German Federal Ministry of Education and Research (KNDD-FTLDc), JPND (Prefrontals), Thierry Latran foundation, Foundation of the state Baden-Wuerttemberg, Boehringer Ingelheim Ulm University BioCenter (BIU), and German Research Foundation (SFB 1279). Go to Neurology.org for full disclosures.

PY - 2017

Y1 - 2017

UR - http://www.scopus.com/inward/record.url?scp=85044043771&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85044043771&partnerID=8YFLogxK

U2 - 10.1212/WNL.0000000000004675

DO - 10.1212/WNL.0000000000004675

M3 - Editorial

C2 - 29070663

AN - SCOPUS:85044043771

VL - 89

SP - 2126

EP - 2127

JO - Neurology

JF - Neurology

SN - 0028-3878

IS - 21

ER -